semaglutide trial adolescents obesity 2022 #VisualAbstract: Treatment with reduced body mass index in with Effect of semaglutide 2.4 mg

Results Disclaimer: Individual results from GLP-1 weight loss treatment vary based on factors including age, baseline health condition, metabolic profile, consistency of use, dietary habits, physical activity levels, genetic factors, and adherence to clinical guidance

However, directly comparing their efficacy is challenging due to differences in study designs, patient populations, and treatment durations

This is particularly significant for patients with fatty liver disease, metabolic syndrome, or those recovering from illness, where this clearance function is often impaired

So the question is not could this happen? but rather how often does it happen, why, and how serious is it? What Large Clinical Trials Show Large randomized controlled trials (RCTs) are the backbone of medication safety